Ring-fused compound
US8987473B2 · kind B2 · utility
11Cited by
6References
18Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 30, 2012 |
| Grant date | Mar 24, 2015 |
| Priority date | — |
| Expiry date | Jan 30, 2032 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D413/06
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The present invention relates to a compound that has URAT1 inhibitory action, and a URAT1 inhibitor, a blood uric acid level-reducing agent and a pharmaceutical composition comprising the compound. More specifically, the present invention relates to a compound represented by Formula (I) below.[in the formula,
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.